Company news

Sutro Biopharma, Inc. news in 2022

Sutro Biopharma, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Sutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/Refractory CBF/GLIS AML at ASH 2022

December 9, 2022

Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones

November 7, 2022

Sutro Biopharma Announces Oral Presentation at the 64th American Society of Hematology Annual Meeting and Exposition

November 2, 2022

Sutro Biopharma Announces Departure of Chief Medical Officer

October 23, 2022

Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones

August 7, 2022

Sutro Biopharma Achieves “First in Human” Milestone in Cytokine Derivatives Collaboration with Merck

July 25, 2022

Sutro Biopharma Announces Virtual Deep Dive Research Forum: Next-Gen Innovations in ADCs

July 11, 2022

Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones

May 8, 2022

Sutro Biopharma Presents Nonclinical Data for Antibody-Drug Conjugate STRO-002 at the AACR Annual Meeting 2022

April 7, 2022

Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones

February 27, 2022

Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer

January 4, 2022

Decks in 2022